Catalent Biologics is your one integrated partner with expertise to get your biologic to market faster. We have the passion to help you accelerate, simplify and de-risk your next biologic from development and manufacturing, to fill/finish, clinical supply and commercial launch.
- GPEx® Cell Line Development Technology - Create stable, high-yielding mammalian cell lines for even the most difficult to express proteins with proven GPEx® technology.
- SMARTag® ADC & Bioconjugates Technology - Develop more efficacious antibody drug conjugates faster with >95% tag conversion yields and conjugation yields.
- Biologics Analytical Services - Comprehensive standalone or integrated solutions for drug substance, drug product and intermediates with support from pre-clinical testing through commercial release and stability.
- Development & Biomanufacturing - State-of-the-art facilities offering right scale flexible clinical and commercial manufacturing, integrated process development, and analytical services to solve your most difficult development and biomanufacturing challenges.biologics analytical services Comprehensive standalone or integrated solutions for drug substance, drug product and intermediates with support from pre-clinical testing through commercial release and stability.
- Drug Product Fill/Finish - Flexible solutions for vial, syringe and cartridge filling based on specific needs with integrated formulation development and packaging capabilities, including safety device and auto-injector assembly with full analytical support.
- Clinical Supply Services - Comprehensive clinical supply services including commercial drug sourcing, prefilled syringe finishing, extensive cold chain capabilities and global distribution.
- Paragon Gene Therapy - Industry leading capabilities and expertise in the development and manufacturing of adeno-associated virus (AAV) vectors, the predominant delivery vehicles for gene therapies
- ONEBIOsm Integrated Suite - A single solution from cell line development through clinical and commercial manufacturing and supply to reduce timelines, risk and complexity